Your browser doesn't support javascript.
loading
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score.
Huynh-Le, Minh-Phuong; Karunamuni, Roshan; Fan, Chun Chieh; Asona, Lui; Thompson, Wesley K; Martinez, Maria Elena; Eeles, Rosalind A; Kote-Jarai, Zsofia; Muir, Kenneth R; Lophatananon, Artitaya; Schleutker, Johanna; Pashayan, Nora; Batra, Jyotsna; Grönberg, Henrik; Neal, David E; Nordestgaard, Børge G; Tangen, Catherine M; MacInnis, Robert J; Wolk, Alicja; Albanes, Demetrius; Haiman, Christopher A; Travis, Ruth C; Blot, William J; Stanford, Janet L; Mucci, Lorelei A; West, Catharine M L; Nielsen, Sune F; Kibel, Adam S; Cussenot, Olivier; Berndt, Sonja I; Koutros, Stella; Sørensen, Karina Dalsgaard; Cybulski, Cezary; Grindedal, Eli Marie; Menegaux, Florence; Park, Jong Y; Ingles, Sue A; Maier, Christiane; Hamilton, Robert J; Rosenstein, Barry S; Lu, Yong-Jie; Watya, Stephen; Vega, Ana; Kogevinas, Manolis; Wiklund, Fredrik; Penney, Kathryn L; Huff, Chad D; Teixeira, Manuel R; Multigner, Luc; Leach, Robin J.
Afiliação
  • Huynh-Le MP; Radiation Oncology, George Washington University, Washington, DC, USA.
  • Karunamuni R; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
  • Fan CC; Center for Multimodal Imaging and Genetics, University of California San Diego, La Jolla, CA, USA.
  • Asona L; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
  • Thompson WK; Center for Multimodal Imaging and Genetics, University of California San Diego, La Jolla, CA, USA.
  • Martinez ME; Center for Multimodal Imaging and Genetics, University of California San Diego, La Jolla, CA, USA.
  • Eeles RA; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
  • Kote-Jarai Z; Division of Biostatistics and Halicioglu Data Science Institute, University of California San Diego, La Jolla, CA, USA.
  • Muir KR; Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
  • Lophatananon A; University of California San Diego, Moores Cancer Center, Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, 92093-0012, USA.
  • Schleutker J; The Institute of Cancer Research, London, SM2 5NG, UK.
  • Pashayan N; Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.
  • Batra J; The Institute of Cancer Research, London, SM2 5NG, UK.
  • Grönberg H; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
  • Neal DE; Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
  • Nordestgaard BG; Institute of Biomedicine, University of Turku, Turku, Finland.
  • Tangen CM; Department of Medical Genetics, Genomics, Laboratory Division, Turku University Hospital, PO Box 52, 20521, Turku, Finland.
  • MacInnis RJ; Department of Applied Health Research, University College London, London, WC1E 7HB, UK.
  • Wolk A; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK.
  • Albanes D; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, 4059, Australia.
  • Haiman CA; Translational Research Institute, Brisbane, QLD, 4102, Australia.
  • Travis RC; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, SE-171 77, Stockholm, Sweden.
  • Blot WJ; Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK.
  • Stanford JL; University of Cambridge, Department of Oncology, Box 279, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
  • Mucci LA; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, CB2 0RE, UK.
  • West CML; Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
  • Nielsen SF; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark.
  • Kibel AS; SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Cussenot O; Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.
  • Berndt SI; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Grattan Street, Parkville, VIC, 3010, Australia.
  • Koutros S; Department of Surgical Sciences, Uppsala University, 75185, Uppsala, Sweden.
  • Sørensen KD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, 20892, USA.
  • Cybulski C; Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, 90015, USA.
  • Grindedal EM; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.
  • Menegaux F; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 800, Nashville, TN, 37232, USA.
  • Park JY; International Epidemiology Institute, Rockville, MD, 20850, USA.
  • Ingles SA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109-1024, USA.
  • Maier C; Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, 98195, USA.
  • Hamilton RJ; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, 02115, USA.
  • Rosenstein BS; Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester, M13 9PL, UK.
  • Lu YJ; Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
  • Watya S; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, 2200, Copenhagen, Denmark.
  • Vega A; Division of Urologic Surgery, Brigham and Womens Hospital, 75 Francis Street, Boston, MA, 02115, USA.
  • Kogevinas M; Sorbonne Universite, GRC n°5, AP-HP, Tenon Hospital, 4 rue de la Chine, F-45020, Paris, France.
  • Wiklund F; CeRePP, Tenon Hospital, F-75020, Paris, France.
  • Penney KL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, 20892, USA.
  • Huff CD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD, 20892, USA.
  • Teixeira MR; Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensen Boulevard 99, 8200, Aarhus N, Denmark.
  • Multigner L; Department of Clinical Medicine, Aarhus University, DK, 8200, Aarhus N, Denmark.
  • Leach RJ; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, 70-115, Szczecin, Poland.
Prostate Cancer Prostatic Dis ; 25(4): 755-761, 2022 04.
Article em En | MEDLINE | ID: mdl-35152271
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antígeno Prostático Específico Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans / Male Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos